Litcius/Paper detail

Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures

Camilla Margaroli, Paul Benson, Nirmal Sharma, Matthew C. Madison, Sarah W. Robison, Nitin Arora, Kathy Ton, Yan Liang, Liang Zhang, Rakesh P. Patel, Amit Gaggar

2021Cell Reports Medicine57 citationsDOIOpen Access PDF

Abstract

Severe SARS-CoV-2 infection often leads to the development of acute respiratory distress syndrome (ARDS), with profound pulmonary patho-histological changes post-mortem. It is not clear whether ARDS from SARS-CoV-2 is similar to that observed in influenza H1N1, another common viral cause of lung injury. Here, we analyze specific ARDS regions of interest utilizing a spatial transcriptomic platform on autopsy-derived lung tissue from patients with SARS-CoV-2 (n = 3), H1N1 (n = 3), and a dual infected individual (n = 1). Enhanced gene signatures in alveolar epithelium, vascular tissue, and lung macrophages identify not only increased regional coagulopathy but also increased extracellular remodeling, alternative macrophage activation, and squamous metaplasia of type II pneumocytes in SARS-CoV-2. Both the H1N1 and dual-infected transcriptome demonstrated an enhanced antiviral response compared to SARS-CoV-2. Our results uncover regional transcriptional changes related to tissue damage/remodeling, altered cellular phenotype, and vascular injury active in SARS-CoV-2 and present therapeutic targets for COVID-19-related ARDS.

Topics & Concepts

ARDSDiffuse alveolar damageLungTranscriptomePathologyBiologyImmunologyMedicineAcute respiratory distressGene expressionGeneInternal medicineGeneticsCOVID-19 Clinical Research Studiesinterferon and immune responsesImmune cells in cancer
Spatial mapping of SARS-CoV-2 and H1N1 lung injury identifies differential transcriptional signatures | Litcius